Atlas Trials

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients

Clinical trial NCT01465503 · COMPLETED

Trial details

NCT number
NCT01465503
Sponsor
Clinica Mediterranea
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bleeding
Start date
2008-01-01
Primary completion
2012-12-01
Enrollment
837

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.